Skip to content

Author

L. Hou

We have 2 of 35 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

SGPP1 as a tumor suppressor in esophageal squamous cell carcinoma: Potential molecular mechanisms involving UGT1A9/UGT2B28 and clinical prognostic significance.

SGPP1 functions as a tumor suppressor gene in ESCC and may inhibit tumor progression by regulating UGT1A9/UGT2B28‑mediated metabolic pathways and serve as a prognostic biomarker and a potential therapeutic target in ESCC.

L. Su, L. Hou, Xue-Tao Han et al. · 0 citations
Review Aug 2026

Unraveling the pro-oncogenic role of GLIPR2: Its molecular basis in glioma malignancy.

Findings identify GLIPR2 as a glioma-associated biomarker linked to malignant progression, unfavorable prognosis, and radioresistance and nominate it as an investigational molecular vulnerability for further validation.

T. Fan, Yu Wang, Sijie Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.